Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,400
Closed -$555K 843
2019
Q4
$555K Sell
13,400
-7
-0.1% -$295 0.03% 396
2019
Q3
$613K Buy
13,407
+7
+0.1% +$305 0.04% 324
2019
Q2
$578K Buy
13,400
+4,627
+53% +$195K 0.03% 296
2019
Q1
$381K Sell
8,773
-1,978
-18% -$101K 0.02% 337
2018
Q4
$508K Buy
10,751
+51
+0.5% +$3.06K 0.03% 322
2018
Q3
$799K Sell
10,700
-4,315
-29% -$297K 0.03% 323
2018
Q2
$829K Buy
15,015
+5,115
+52% +$236K 0.03% 350
2018
Q1
$377K Sell
9,900
-2,600
-21% -$80.5K 0.01% 468
2017
Q4
$350K Sell
12,500
-3,437
-22% -$105K 0.01% 473
2017
Q3
$494K Buy
15,937
+137
+0.9% +$3.73K 0.02% 429
2017
Q2
$445K Buy
+15,800
New +$382K 0.02% 420
2015
Q3
Sell
-13,478
Closed -$316K 1543
2015
Q2
$316K Buy
+13,478
New +$338K 0.01% 1123
2014
Q2
Sell
-12,700
Closed -$287K 1615
2014
Q1
$287K Buy
+12,700
New +$310K 0.01% 1126

Other funds holding SRDX

PDT Partners's SRDX Position: Q1 2020 in Review

PDT Partners sold out of Surmodics (SRDX) in Q1 2020, closing a stake of 13,400 shares — an estimated $555K sold.

PDT Partners first reported a position in SRDX in Q1 2014 and held it in 13 quarters. The position peaked at $829K in Q2 2018. 127 funds tracked by Wall St. Rank hold SRDX as of Q1 2020.

  • PDT Partners reported no remaining Surmodics position as of Q1 2020 after selling out during the quarter.
  • PDT Partners sold 13,400 Surmodics shares in Q1 2020, an estimated $555K.
  • PDT Partners first reported a position in Surmodics in Q1 2014 and held it in 13 quarters.
  • PDT Partners's Surmodics position peaked at $829K in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Surmodics as of Q1 2020.

Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.